688488 Stock Overview
Develops, produces, and sells pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Jiangsu Aidea Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.16 |
| 52 Week High | CN¥17.40 |
| 52 Week Low | CN¥6.58 |
| Beta | 0.44 |
| 11 Month Change | 2.69% |
| 3 Month Change | 20.37% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -24.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688488 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -1.3% | -2.6% | -2.1% |
| 1Y | n/a | -20.9% | 2.8% |
Return vs Industry: Insufficient data to determine how 688488 performed against the CN Biotechs industry.
Return vs Market: Insufficient data to determine how 688488 performed against the CN Market.
Price Volatility
| 688488 volatility | |
|---|---|
| 688488 Average Weekly Movement | 11.3% |
| Biotechs Industry Average Movement | 8.9% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 688488's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 688488's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 491 | Jie Zhang | www.aidea.com.cn |
Jiangsu Aidea Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and HIV diagnostic equipment and reagents. The company was founded in 2009 and is headquartered in Yangzhou, China.
Jiangsu Aidea Pharmaceutical Co., Ltd. Fundamentals Summary
| 688488 fundamental statistics | |
|---|---|
| Market cap | CN¥3.85b |
| Earnings (TTM) | -CN¥104.55m |
| Revenue (TTM) | CN¥408.68m |
9.4x
P/S Ratio-36.9x
P/E RatioIs 688488 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688488 income statement (TTM) | |
|---|---|
| Revenue | CN¥408.68m |
| Cost of Revenue | CN¥227.38m |
| Gross Profit | CN¥181.30m |
| Other Expenses | CN¥285.85m |
| Earnings | -CN¥104.55m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.25 |
| Gross Margin | 44.36% |
| Net Profit Margin | -25.58% |
| Debt/Equity Ratio | 41.4% |
How did 688488 perform over the long term?
See historical performance and comparison